Comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis
- PMID: 35318717
- PMCID: PMC9253068
- DOI: 10.1111/1346-8138.16354
Comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis
Conflict of interest statement
CONFLICTS OF INTEREST
SFT is the Co-founder, President and CEO of PXE International, the international advocacy organization for pseudoxanthoma elasticum (PXE). The other authors have no conflicts to declare.
Comment in
-
Author reply to comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis.J Dermatol. 2022 Jul;49(7):e250. doi: 10.1111/1346-8138.16379. Epub 2022 Apr 8. J Dermatol. 2022. PMID: 35394086 No abstract available.
Comment on
-
Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee.J Dermatol. 2022 Mar;49(3):e91-e98. doi: 10.1111/1346-8138.16301. Epub 2022 Jan 12. J Dermatol. 2022. PMID: 35019155
References
-
- Iwanaga A, Utani A, Koike Y et al. Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee. J Dermatol 2022. DOI: 10.1111/1346-8138.16301. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources